approval
saveGABAPENTIN — FDA approval
community read0 votes
Sponsor: STRIDES PHARMA. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalGABAPENTIN — FDA approvalMar 6, 2026 · 214d ago
- approvalGABAPENTIN — FDA approvalJan 29, 2026 · 250d ago
- approvalGABAPENTIN — FDA approvalJan 29, 2026 · 250d ago
- approvalGABAPENTIN — FDA approvalDec 17, 2025 · 293d ago
- approvalGABAPENTIN — FDA approvalNov 24, 2025 · 316d ago
- approvalGABAPENTIN — FDA approvalSep 19, 2025 · 382d ago
- approvalGABAPENTIN — FDA approvalJul 21, 2025 · 442d ago
- approvalGABAPENTIN — FDA approvalJul 21, 2025 · 442d ago
same company · ±60 days · 6
- recallSTRIDES PHARMA INC recall (Cls II)Mar 25, 2026
- approvalMYCOPHENOLATE MOFETIL: MYCOPHENOLATE MOFETIL — FDA approvalApr 10, 2026
- approvaltramadol hydrochloride ER: TRAMADOL HYDROCHLORIDE — FDA approvalMar 23, 2026
- approvaldoxycycline ER: DOXYCYCLINE — FDA approvalMar 20, 2026
- approvalCABERGOLINE: CABERGOLINE — FDA approvalMar 18, 2026
- approvaldoxycycline ER: DOXYCYCLINE — FDA approvalMar 11, 2026
🐶 often sniffed alongside
top 8- tagApproval240 co-mentions · 120 sources
- drugGralise127 co-mentions · 127 sources
- drugNeurontin127 co-mentions · 127 sources
- tagSmall Molecule120 co-mentions · 120 sources
- companyActavis Elizabeth LLC18 co-mentions · 18 sources
- companyStrides Pharma Inc13 co-mentions · 13 sources
- tagRecall7 co-mentions · 7 sources
- companySun Pharmaceutical Industries Ltd6 co-mentions · 2 sources
comments(0)
5-min edit window · permanent after that